How A Regional Pharmaceutical Leader Maintained Compliance Through Divestiture Without Disrupting Operations
By Anand Shukla

Divestitures in the life sciences sector create unique challenges for preserving access to historical quality records. When a manufacturing site changes ownership, both the divesting and receiving organizations must ensure continued access to legacy Quality Management System (QMS) data while meeting strict transition timelines, safeguarding sensitive information, and maintaining regulatory readiness. Legacy systems are rarely built to support this kind of separation, making it difficult to isolate site-specific records without exposing unrelated or restricted data.
This case study explores how one organization navigated a complex divestiture with a “full copy, then scrub” approach. The validated, site-specific records were then archived in a secure, audit-ready environment. The result: uninterrupted business operations, regulatory confidence, and a reusable framework for future transactions. For organizations facing an upcoming divestiture, this resource offers a practical approach to protecting historical quality data and avoiding the operational risks that often accompany large-scale data transitions.
Get unlimited access to:
Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.